Detalhe da pesquisa
1.
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
BMC Cancer
; 21(1): 64, 2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446148
2.
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study.
Future Oncol
; 17(14): 1777-1791, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590772
3.
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.
Thromb Haemost
; 122(10): 1653-1661, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381615
4.
Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.
Sci Rep
; 6: 37820, 2016 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27901069
5.
Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.
Cancers (Basel)
; 6(1): 153-65, 2014 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452143